pmc logo image
Logo of califmedJournal URL: tocrender.fcgi?issn=0093-0415&action=archive
Journal List > Calif Med > v.107(1); Jul 1967

Formats:
Calif Med. 1967 July; 107(1): 33–46.
PMCID: PMC1502847
Copyright notice
Pressor agents.
N T Smith
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 33
33
icon of scanned page 34
34
icon of scanned page 35
35
icon of scanned page 36
36
icon of scanned page 37
37
icon of scanned page 38
38
icon of scanned page 39
39
icon of scanned page 40
40
icon of scanned page 41
41
icon of scanned page 42
42
icon of scanned page 43
43
icon of scanned page 44
44
icon of scanned page 45
45
icon of scanned page 46
46
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • ALDINGER EE. EFFECTS OF SEVERAL CARDIOVASCULAR DRUGS ON VARIOUS PHASES OF CIRCULATORY DYNAMICS. Am Heart J. 1964 Jul;68:55–65. [PubMed]
  • ALI HI, ANTONIO A, HAUGAARD N. THE ACTION OF SYMPATHOMIMETIC AMINES AND ADRENERGIC BLOCKING AGENTS ON TISSUE PHOSPHORYLASE ACTIVITY. J Pharmacol Exp Ther. 1964 Aug;145:142–150. [PubMed]
  • Altura BM, Hershey SG, Mazzia VD. Microcirculatory approach to vasopressor therapy in intestinal ischemic (SMA) shock. Am J Surg. 1966 Feb;111(2):186–192. [PubMed]
  • ANDERSEN TW, GRAVENSTEIN JS. MEPHENTERMINE AND EPHEDRINE IN MAN; A COMPARATIVE STUDY ON CARDIOVASCULAR EFFECTS. Clin Pharmacol Ther. 1964 May–Jun;5:281–285. [PubMed]
  • AVIADO DM. PHARMACOLOGIC APPROACH TO THE TREATMENT OF SHOCK. Ann Intern Med. 1965 May;62:1050–1059. [PubMed]
  • AVIADO DM, Jr, SCHMIDT CF. Effects of sympathomimetic drugs on pulmonary circulation: with special reference to a new pulmonary vasodilator. J Pharmacol Exp Ther. 1957 Aug;120(4):512–527. [PubMed]
  • BAGWELL EE, WOODS EF, DURST GG., Jr INFLUENCE OF RESERPINE ON CARDIOVASCULAR AND SYMPATHO-ADRENAL RESPONSES TO CYCLOPROPANE ANESTHESIA IN THE DOG. Anesthesiology. 1964 Mar–Apr;25:148–155. [PubMed]
  • BENDIXEN HH, OSGOOD PF, HALL KV, LAVER MB. DOSE-DEPENDENT DIFFERENCES IN CATECHOLAMINE ACTION ON HEART AND PERIPHERY. J Pharmacol Exp Ther. 1964 Sep;145:299–306. [PubMed]
  • BERNSTEIN A, SIMON F, ROTHFELD EJ, ROBINS B, COHEN FB, KAUFMAN JG. Treatment of shock in myocardial infarction. Am J Cardiol. 1962 Jan;9:74–81. [PubMed]
  • BERRY WB, AUSTEN WG, CLARK WD. STUDIES ON THE RELATIVE CARDIAC AND PERIPHERAL ACTIONS OF ANGIOTENSIN. Ann Surg. 1964 Apr;159:520–528. [PubMed]
  • BIANCHI A, DE SCHAEPDRYVER AF, DE VLEESCHHOUWER GR, PREZIOSI P. On the pharmacology of synthetic hypertensine. Arch Int Pharmacodyn Ther. 1960 Feb 1;124:21–44. [PubMed]
  • Binder MJ. Effect of vasopressor drugs on circulatory dynamics in shock following myocardial infarction. Am J Cardiol. 1965 Dec;16(6):834–840. [PubMed]
  • BLOCH JH, PIERCE CH, MANAX WG, LILLEHEI RC. TREATMENT OF EXPERIMENTAL CARDIOGENIC SHOCK. Surgery. 1965 Jul;58:197–214. [PubMed]
  • Botticelli JT, Tsagaris TJ, Lange RL. Mechanisms of pressor amine dependence. Am J Cardiol. 1965 Dec;16(6):847–858. [PubMed]
  • BRAUNWALD E, CHIDSEY CA, HARRISON DC, GAFFNEY TE, KAHLER RL. STUDIES ON THE FUNCTION OF THE ADRENERGIC NERVE ENDINGS IN THE HEART. Circulation. 1963 Nov;28:958–969. [PubMed]
  • BRODIE BB. RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE. Circulation. 1963 Nov;28:970–986. [PubMed]
  • BROFMAN BL, HELLERSTEIN HK, CASKEY WH. Mephentermine: an effective pressor amine; clinical and laboratory observations. Am Heart J. 1952 Sep;44(3):396–406. [PubMed]
  • Brown E, Goei JS, Greenfield AD, Plassaras GC. Circulatory responses to simulated gravitational shifts of blood in man induced by exposure of the body below the iliac crests to sub-atmospheric pressure. J Physiol. 1966 Apr;183(3):607–627. [PubMed]
  • LANDS AM, BROWN TG., Jr A COMPARISON OF THE CARDIAC STIMULATING AND BRONCHODILATOR ACTIONS OF SELECTED SYMPATHOMIMETIC AMINES. Proc Soc Exp Biol Med. 1964 Jun;116:331–333. [PubMed]
  • BRYANT MF, HOWARD JM. Necrotizing properties of metaraminol (aramine) and arterenol (norepinephrine); comparative study. AMA Arch Surg. 1957 Dec;75(6):1020–1022. [PubMed]
  • BURN JH, RAND MJ. Fall of blood pressure after a noradrenaline infusion and its treatment by pressor agents. Br Med J. 1959 Feb 14;1(5119):394–397. [PubMed]
  • BURN JH, RAND MJ. The action of sympathomimetic amines in animals treated with reserpine. J Physiol. 1958 Dec 4;144(2):314–336. [PubMed]
  • COAKLEY CS, ALPERT S, BOLING JS. Circulatory responses during anesthesia of patients on Rauwolfia therapy. J Am Med Assoc. 1956 Jul 21;161(12):1143–1144. [PubMed]
  • COLON-YORDAN E, JIMENEZ-VELEZ JL. Effects of intravenous atropine and scopolamine during cyclopropanesuccinylcholine anesthesia. Anesthesiology. 1962 May–Jun;23:333–341. [PubMed]
  • COVINO BG. Autifibrillary effect of mephentermine sulfate (wyamine) in general hypothermia. J Pharmacol Exp Ther. 1958 Mar;122(3):418–422. [PubMed]
  • COVINO BG, MARGOLIS N, D'AMATO HE. Effect of various drugs on spontaneous and surgically induced ventricular fibrillation in hypothermia. Am Heart J. 1959 Nov;58:750–754. [PubMed]
  • CRANDELL DL. The anesthetic hazards in patients on antihypertensive therapy. JAMA. 1962 Feb 17;179:495–500. [PubMed]
  • CROUT JR, ALPERS HS, TATUM EL, SHORE PA. RELEASE OF METARAMINOL (ARAMINE) FROM THE HEART BY SYMPATHETIC NERVE STIMULATION. Science. 1964 Aug 21;145:828–829. [PubMed]
  • CUMMINGS JR, HAYS HW. Cardiovascular studies of adrenergic and ganglionic stimulating drugs administered during cyclopropane. Anesthesiology. 1956 Mar;17(2):314–324. [PubMed]
  • Dagher FJ, Lyons JH, Lister J, Moore FD. Hemorrhage in normal man. The effects of angiotensin. J Surg Res. 1966 Feb;6(2):66–73. [PubMed]
  • DARBY TD, ALDINGER EE, GADSDEN RH, THROWER WB. Effects of metabolic acidosis on ventricular isometric systolic tension and the response to epinephrine and levarterenol. Circ Res. 1960 Nov;8:1242–1253. [PubMed]
  • DUNER H, VON EULER US. Secondary fall in blood pressure following noradrenaline infusion in the cat. Acta Physiol Scand. 1957 Mar 7;38(3-4):355–363. [PubMed]
  • DUKE M, AMES RP, ABELMANN WH. HEMODYNAMIC EFFECTS OF METHOXAMINE IN NORMAL HUMAN SUBJECTS. Am J Med Sci. 1963 Sep;246:301–307. [PubMed]
  • EAKINS KE, LOCKETT MF. The formation of an isoprenaline-like substance from adrenaline. Br J Pharmacol Chemother. 1961 Feb;16:108–115. [PubMed]
  • ECKFELD DK, ABELL LL, SEIFTER J. Pharmacological properties of mephentermine, a sympathomimetic amine. J Am Pharm Assoc Am Pharm Assoc (Baltim). 1954 Dec;43(12):705–708. [PubMed]
  • EGER EI., 2nd Atropine, scopolamine, and related compounds. Anesthesiology. 1962 May–Jun;23:365–383. [PubMed]
  • ELLIS CH. CONTROL OF VENTRICULAR TACHYCARDIAS IN DOGS BY B.W. 62-235, A DERIVATIVE OF METHOXAMINE. Arch Int Pharmacodyn Ther. 1964 Jul 1;150:144–154. [PubMed]
  • ELLIS CH. INFLUENCE OF CERTAIN PHENYLALKYLAMINES ON DEPRESSION OF CARDIAC CONTRACTILITY BY CALCIUM CHELATERS. Arch Int Pharmacodyn Ther. 1965 Mar;154:26–39. [PubMed]
  • FAWAZ G. The effect of mephentermine on isolated dog hearts, normal and pretreated with reserpine. Br J Pharmacol Chemother. 1961 Jun;16:309–314. [PubMed]
  • FERRANS VJ, HIBBS RG, BLACK WC, WEILBAECHER DG. ISOPROTERENOL-INDUCED MYOCARDIAL NECROSIS. A HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDY. Am Heart J. 1964 Jul;68:71–90. [PubMed]
  • FINNERTY FA., Jr Hemodynamics of angiotensin in man. Circulation. 1962 Jan;25:255–258. [PubMed]
  • FOWLER NO, HOLMES JC. CORONARY AND MYOCARDIAL ACTIONS OF ANGIOTENSIN. Circ Res. 1964 Mar;14:191–201. [PubMed]
  • FREIHEIT HJ. Preliminary observations on the positive inotropic effects of mephentermine. Int Rec Med Gen Pract Clin. 1957 Sep;170(9):510–514. [PubMed]
  • FRYE RL, BRAUNWALD E. Studies on Starling's law of the heart. I. The circulatory response to acute hypervolemia and its modification by ganglionic blockade. J Clin Invest. 1960 Jul;39:1043–1050. [PubMed]
  • GAZES PC, GOLDBERG LI, DARBY TD. Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction. Circulation. 1953 Dec;8(6):883–892. [PubMed]
  • GILBERT JL, LANGE G, BROOKS CM. Influence of sympathomimetic pressor drugs on arrhythmias caused by multiple stimuli. Circ Res. 1959 May;7(3):417–423. [PubMed]
  • GILBERT JL, LANGE G, POLEVOY I, BROOKS CM. Effects of vasoconstrictor agents on cardiac irritability. J Pharmacol Exp Ther. 1958 May;123(1):9–15. [PubMed]
  • GLASSMAN JM, SEIFTER J. The effect of mephentermine on hypodynamic and arrhythmic isolated frog hearts. J Pharmacol Exp Ther. 1954 Nov;112(3):364–373. [PubMed]
  • GOLDBERG LI, BLOODWELL RD, BRAUNWALD E, MORROW AG. The direct effects of norepinephrine, epinephrine, and methoxamine on myocardial contractile force in man. Circulation. 1960 Dec;22:1125–1132. [PubMed]
  • GOLDFIEN A. PHEOCHROMOCYTOMA: DIAGNOSIS AND ANESTHETIC AND SURGICAL MANAGEMENT. Anesthesiology. 1963 Jul–Aug;24:462–471. [PubMed]
  • GREEN HD, BLUMBERG JB. THE USE OF A SYNTHETIC ANALOGUE OF POSTHYPOPHYSIAL VASOPRESSIN (PLV-2) FOR LOCAL HEMOSTASIS. Surgery. 1965 Sep;58:524–529. [PubMed]
  • Haefely W, Hürlimann A, Thoenen H. The effect of stimulation of sympathetic nerves in the cat treated with reserpine, alpha-methyldopa and alpha-methylmetatyrosine. Br J Pharmacol Chemother. 1966 Jan;26(1):172–185. [PubMed]
  • HAMELBERG W, BOSOMWORTH PP. Evaluation of ephedrine test. JAMA. 1963 Mar 2;183:782–783. [PubMed]
  • HAMIT HF. CURRENT TRENDS OF THERAPY AND RESEARCH IN SHOCK. Surg Gynecol Obstet. 1965 Apr;120:835–854. [PubMed]
  • HARRISON DC, GLICK G, GOLDBLATT A, BRAUNWALD E. STUDIES ON CARDIAC DIMENSIONS IN INTACT, UNANESTHETIZED MAN. IV. EFFECTS OF ISOPROTERENOL AND METHOXAMINE. Circulation. 1964 Feb;29:186–194. [PubMed]
  • HERSHEY SG. DYNAMICS OF PERIPHERAL VASCULAR COLLAPSE IN SHOCK. Int Anesthesiol Clin. 1964 Feb;2:185–200. [PubMed]
  • HINGSON RA, DAVIS HS, INMAN CE, LELIEVRE RE. A clinical evaluation of mephentermine as a vasopressor in surgery and obstetrics. Am Pract Dig Treat. 1955 Jul;6(7):1004–1014. [PubMed]
  • Hong E, Mendoza PA, Pardo EG. Influence of previous reserpine administration on the ganglionic action of selected sympathomimetic amines. Life Sci. 1965 Dec;4(24):2383–2392. [PubMed]
  • IMAI S, SHIGEI T, HASHIMOTO K. Cardiac actions of methoxamine with special reference to its antagonistic action to epinephrine. Circ Res. 1961 May;9:552–560. [PubMed]
  • JACOBSON E, ADELMAN MH. The electrocardiographic effects of intravenous administration of neostigmine and atropine during cyclopropane anesthesia. Anesthesiology. 1954 Jul;15(4):407–415. [PubMed]
  • James TN. Absence of direct chronotropic action of angiotensin infused into the sinus node artery. Am J Physiol. 1965 Sep;209(3):571–576. [PubMed]
  • JOHNSON WP, BRUCE RA. Hemodynamic and metabolic effects of angiotensin II during rest and exercise in normal healthy subjects. Am Heart J. 1962 Feb;63:212–218. [PubMed]
  • JOHNSTONE M. The cardiology of anaesthesia. Curr Res Anesth Analg. 1952 Sep–Oct;31(5):325–331. [PubMed]
  • KARIM SM. SYMPATHETIC BETA-RECEPTOR BLOCKING ACTION OF METHOXAMINE. Br J Pharmacol Chemother. 1965 Apr;24:365–374. [PubMed]
  • KOCH-WESER J. MYOCARDIAL ACTIONS OF ANGIOTENSIN. Circ Res. 1964 Apr;14:337–344. [PubMed]
  • KOCH-WESER J. NATURE OF THE INOTROPIC ACTION OF ANGIOTENSIN ON VENTRICULAR MYOCARDIUM. Circ Res. 1965 Mar;16:230–237. [PubMed]
  • KOLOMEYER N. A clinical evaluation of mephentermine sulfate and pentylenetetrazol as stimulant therapy for the geriatric patient. J Am Geriatr Soc. 1958 May;6(5):415–423. [PubMed]
  • KOPIN IJ, FISCHER JE, MUSACCHIO JM, HORST WD, WEISE VK. "FALSE NEUROCHEMICAL TRANSMITTERS" AND THE MECHANISM OF SYMPATHETIC BLOCKADE BY MONOAMINE OXIDASE INHIBITORS. J Pharmacol Exp Ther. 1965 Feb;147:186–193. [PubMed]
  • Krasney JA, Paudler FT, Smith DC, Davis LD, Youmans WB. Mechanisms of cardioaccelerator action of angiotensin. Am J Physiol. 1965 Sep;209(3):539–544. [PubMed]
  • KROGSGAARD AR. The effect of intravenously injected reserpine on blood pressure, renal function and sodium excretion. Acta Med Scand. 1956 Mar 8;154(1):41–51. [PubMed]
  • LAHTI RE, BRILL IC, MCCAWLEY EL. The effect of methoxamine hydrochloride (vasoxyl) on cardiac rhythm. J Pharmacol Exp Ther. 1955 Nov;115(3):268–274. [PubMed]
  • LEVER AF, MOWBRAY JF, PEART WS. Blood flow and blood pressure after noradrenaline infusions. Clin Sci. 1961 Aug;21:69–74. [PubMed]
  • LEVY B. ALTERATIONS OF ADRENERGIC RESPONSES BY N-ISOPROPYLMETHOXAMINE. J Pharmacol Exp Ther. 1964 Oct;146:129–138. [PubMed]
  • LI TH, SHIMOSATO S, ETSTEN B. Hemodynamics of mephentermine in man. N Engl J Med. 1962 Jul 26;267:180–184. [PubMed]
  • LI TH, SHIMOSATO S, GAMBLE CA, ETSTEN BE. HEMODYNAMICS OF MEPHENTERMINE DURING SPINAL ANESTHESIA IN MAN. Anesthesiology. 1963 Nov–Dec;24:817–827. [PubMed]
  • LILLEHEI RC, LONGERBEAM JK, BLOCH JH, MANAX WG. THE MODERN TREATMENT OF SHOCK BASED ON PHYSIOLOGIC PRINCIPLES. Clin Pharmacol Ther. 1964 Jan–Feb;5:63–101. [PubMed]
  • LILLEHEI RC, LONGERBEAM JK, BLOCH JH, MANAX WG. THE NATURE OF EXPERIMENTAL IRREVERSIBLE SHOCK WITH ITS CLINICAL APPLICATION. Int Anesthesiol Clin. 1964 Feb;2:297–363. [PubMed]
  • LILLEHEI RC, LONGERBEAM JK, BLOCH JH, MANAX WG. THE NATURE OF IRREVERSIBLE SHOCK: EXPERIMENTAL AND CLINICAL OBSERVATIONS. Ann Surg. 1964 Oct;160:682–710. [PubMed]
  • LISTER J, MCNEILL IF, MARSHALL VC, PLZAK LF, Jr, DAGHER FJ, MOORE FD. TRANSCAPILLARY REFILLING AFTER HEMORRHAGE IN NORMAL MAN: BASAL RATES AND VOLUMES; EFFECT OF NOREPINEPHRINE. Ann Surg. 1963 Oct;158:698–712. [PubMed]
  • LUNDBERG A. Adrenaline and transmission in the sympathetic ganglion of the cat. Acta Physiol Scand. 1952 Sep 10;26(2-3):252–263. [PubMed]
  • LURIA MH, MILLER AJ, KAPLAN BM. SUCCESSFUL THERAPY OF PROLONGED HYPOTENSION WITH AN ADRENERGIC BETA-RECEPTOR BLOCKING AGENT. Circulation. 1964 Apr;29:SUPPL–SUPPL:498. [PubMed]
  • LYNCH PR, WEBBER DL, OPPENHEIMER MJ. Mephentermine as an antifibrillatory drug against cyclopropane-epinephrine ventricular fibrillation. Anesthesiology. 1955 Jul;16(4):632–642. [PubMed]
  • MARSTON EL, BAREFOOT CA, SPENCER MP. Non-cannulating measurement of coronary blood flow. Surg Forum. 1960;10:636–639. [PubMed]
  • MATTHEWS RJ., Jr The effect of epinephrine, levarterenol, and dl-isoproterenol on transmission in the superior cervical ganglion of the cat. J Pharmacol Exp Ther. 1956 Apr;116(4):433–443. [PubMed]
  • MAZURKIEWICZ IM, MURNAGHAN MF. NORADRENALINE POSTINFUSIONAL HYPOTENSION. Arch Int Pharmacodyn Ther. 1964 Mar 1;148:186–199. [PubMed]
  • Meester WD, Hardman HF, Barboriak JJ. Evaluation of various adrenergic blocking agents in isolated rabbit and turtle hearts. J Pharmacol Exp Ther. 1965 Oct;150(1):34–40. [PubMed]
  • Meier M, Wirz E, Brunner H, Stamm W. Effects of norepinephrine and angiotensin II-amide on coronary flow and myocardial oxygen consumption in the cat. Cardiologia. 1965;47(3):127–138. [PubMed]
  • MINUCK M. Reaction to drugs during surgery and anaesthesia. Can Med Assoc J. 1960 May 14;82:1008–1011. [PubMed]
  • MORAN NC. ADRENERGIC RECEPTORS WITHIN THE CARDIOVASCULAR SYSTEM. Circulation. 1963 Nov;28:987–993. [PubMed]
  • Moss AJ, Vittands I, Schenk EA. Cardiovascular effects of sustained norepinephrine infusions. 1. Hemodynamics. Circ Res. 1966 May;18(5):596–604. [PubMed]
  • MUNSON WM, JENICEK JA. Effect of anesthetic agents on patients receiving reserpine therapy. Anesthesiology. 1962 Nov–Dec;23:741–746. [PubMed]
  • NICKERSON M. VASOCONSTRICTION AND VASODILATATION IN SHOCK. Int Anesthesiol Clin. 1964 Feb;2:385–397. [PubMed]
  • NISHITH SD, DAVIS LD, YOUMANS WB. Cardioaccelerator action of angiotensin. Am J Physiol. 1962 Feb;202:237–240. [PubMed]
  • OPPENHEIMER MJ, LYNCH PR, ASCANIO G. Action of mephentermine on arrhythmias due to pulsus alternans, rapidly discharging single atrial foci and prolonged P-R intervals. Am J Physiol. 1957 Dec;191(3):481–486. [PubMed]
  • PAGE IH, BUMPUS FM. Angiotensin. Physiol Rev. 1961 Apr;41:331–390. [PubMed]
  • PAGE IH, BUMPUS FM. A new hormone, angiotensin. Clin Pharmacol Ther. 1962 Nov–Dec;3:758–773. [PubMed]
  • PEARSON JW, REDDING JS. EPINEPHRINE IN CARDIAC RESUSCITATION. Am Heart J. 1963 Aug;66:210–214. [PubMed]
  • POOLER HE. Atropine, neostigmine and sudden deaths. Anaesthesia. 1957 Apr;12(2):198–202. [PubMed]
  • REDDING JS, PEARSON JW. Resuscitation from asphyxia. JAMA. 1962 Oct 20;182:283–286. [PubMed]
  • REGAN TJ, LONDON BL, BINAK K, HELLEMS HK. Sympathomimetics as antagonists of strophanthidin's ionic and arrhythmic effects. Circ Res. 1962 Jul;11:17–25. [PubMed]
  • REIN J, AUSTEN WG, MORROW DH. EFFECTS OF GUANETHIDINE AND RESERPINE ON THE CARDIAC RESPONSES TO HALOTHANE. Anesthesiology. 1963 Sep–Oct;24:672–675. [PubMed]
  • RIBEILIMA J, WENDT VE, RAMOS H, GUDBJARNASON S, BRUCE TA, BING RJ. THE EFFECTS OF NOREPINEPHRINE ON THE HEMODYNAMICS AND MYOCARDIAL METABOLISM OF NORMAL HUMAN SUBJECTS. Am Heart J. 1964 May;67:672–678. [PubMed]
  • RONA G, CHAPPEL CI, BALAZS T, GAUDRY R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol. 1959 Apr;67(4):443–455. [PubMed]
  • ROSS J, Jr, BRAUNWALD E. THE STUDY OF LEFT VENTRICULAR FUNCTION IN MAN BY INCREASING RESISTANCE TO VENTRICULAR EJECTION WITH ANGIOTENSIN. Circulation. 1964 May;29:739–749. [PubMed]
  • ROSENTHALE ME, DIPALMA JR. Acute tolerance to norepinephrine in dogs. J Pharmacol Exp Ther. 1962 Jun;136:336–343. [PubMed]
  • SAMBHI MP, WEIL MH, UDHOJI VN, SHUBIN H. ADRENOCORTICOIDS IN THE MANAGEMENT OF SHOCK. Int Anesthesiol Clin. 1964 Feb;2:421–433. [PubMed]
  • SANCETTA SM. General and pulmonary hemodynamic effects of pure decapeptide angiotensin in normotensive man. Circ Res. 1960 May;8:616–621. [PubMed]
  • SAYEN JJ, KATCHER AH, SHELDON WF, GILBERT CM., Jr The effect of levarterenol on polarographic myocardial oxygen, the epicardial electrocardiogram and contraction in nonischemic dog hearts and experimental acute regional ischemia. Circ Res. 1960 Jan;8:109–128. [PubMed]
  • Schenk EA, Moss AJ. Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res. 1966 May;18(5):605–615. [PubMed]
  • SCHMIDT JL, FLEMING WW. The structure of sympathomimetics as related to reserpine induced sensitivity changes in the rabbit ileum. J Pharmacol Exp Ther. 1963 Feb;139:230–237. [PubMed]
  • SCHMUTZER KJ, RASCHKE E, MALONEY JV., Jr Intravenous 1-norepinephrine as a casue of reduced plasma volume. Surgery. 1961 Sep;50:452–457. [PubMed]
  • SELZER A, RYTAND DA. Use of drugs in shock accompanying myocardial infarction. J Am Med Assoc. 1958 Oct 11;168(6):762–768. [PubMed]
  • SHIRES GT, CARRICO CJ, COLN D. THE ROLE OF THE EXTRACELLULAR FLUID IN SHOCK. Int Anesthesiol Clin. 1964 Feb;2:435–454. [PubMed]
  • Shore PA. The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase. Pharmacol Rev. 1966 Mar;18(1):561–568. [PubMed]
  • SMITH LL, MOORE FD. Refractory hypotension in man--is this irreversible shock? N Engl J Med. 1962 Oct 11;267:733–742. [PubMed]
  • Snow PJ. Effect of propranolol in myocardial infarction. Lancet. 1965 Sep 18;2(7412):551–553. [PubMed]
  • Sodhi HK, Booker WM, Bhagat B. The effect of mephentermine on digitalis-induced arrhythmias. Arch Int Pharmacodyn Ther. 1966 May;161(1):132–137. [PubMed]
  • BARRERA F, LYNCH PR, OPPENHEIMER MJ, STEWART GH., 3rd Changes in properties of heart muscle due to mephentermine. Am J Physiol. 1956 Sep;186(3):513–517. [PubMed]
  • SZAKACS JE, CANNON A. L-Norepinephrine myocarditis. Am J Clin Pathol. 1958 Nov;30(5):425–434. [PubMed]
  • SZAKACS JE, MEHLMAN B. Pathologic changes induced by 1-norepineprine: quantitative aspects. Am J Cardiol. 1960 May;5:619–627. [PubMed]
  • TEXTER EC, Jr, CHOU CC, MERRILL SL, LAURETA HC, FROHLICH ED. DIRECT EFFECTS OF VASOACTIVE AGENTS ON SEGMENTAL RESISTANCE OF THE MESENTERIC AND PORTAL CIRCULATION. STUDIES WITH 1-EPINEPHRINE, LEVARTERENOL, ANGIOTENSIN, VASOPRESSIN, ACETYLCHOLINE, METHACHOLINE, HISTAMINE, AND SEROTONIN. J Lab Clin Med. 1964 Oct;64:624–633. [PubMed]
  • UDHOJI VN, WEIL MH. CIRCULATORY EFFECTS OF ANGIOTENSIN, LEVARTERENOL AND METARAMINOL IN THE TREATMENT OF SHOCK. N Engl J Med. 1964 Mar 5;270:501–505. [PubMed]
  • Udhoji VN, Weil MH. Vasodilator action of a "pressor amine," mephentermine (Wyamine), in circulatory shock. Am J Cardiol. 1965 Dec;16(6):841–846. [PubMed]
  • UDHOJI VN, WEIL MH, SAMBHI MP. PRESSOR AMINES AND ANGIOTENSIN IN THE TREATMENT OF SHOCK. Int Anesthesiol Clin. 1964 Feb;2:399–419. [PubMed]
  • VANDAM LD. THE UNFAVOURABLE EFFECTS OF PROLONGED ANAESTHESIA. Can Anaesth Soc J. 1965 Mar;12:107–120. [PubMed]
  • VANDAM LD, HARRISON JH, MURRAY JE, MERRILL JP. Anesthetic aspects of renal homotransplantation in man. With notes on the anesthetic care of the uremic patient. Anesthesiology. 1962 Nov–Dec;23:783–792. [PubMed]
  • WELCH GH, Jr, BRAUNWALD E, CASE RB, SARNOFF SJ. The effect of mephentermine sulfate on myocardial oxygen consumption, myocardial efficiency and peripheral vascular resistance. Am J Med. 1958 Jun;24(6):871–881. [PubMed]
  • WILSON M, PEREZ-ARZOLA M, OPPENHEIMER MJ. Mephentermine and the arrhythmias. Am J Med Sci. 1958 Sep;236(3):300–310. [PubMed]
  • YU PN, LURIA MN, FINLAYSON JK, STANFIELD CA, CONSTANTINE H, FLATLEY FJ. The effects of angiotensin on pulmonary circulation and ventricular function. Circulation. 1961 Dec;24:1326–1337. [PubMed]
  • YURCHAK PM, ROLETT EL, COHEN LS, GORLIN R. EFFECTS OF NOREPINEPHRINE ON THE CORONARY CIRCULATION IN MAN. Circulation. 1964 Aug;30:180–187. [PubMed]
  • ZIEGLER CH, LOVETTE JB. Operative complications after therapy with reserpine and reserpine compounds. JAMA. 1961 Jun 17;176:916–919. [PubMed]
  • ZIMMERMAN BG, ABBOUD FM, ECKSTEIN JW. Comparison of the effects of sympathomimetic amines upon venous and total vascular resistance in the foreleg of the dog. J Pharmacol Exp Ther. 1963 Mar;139:290–295. [PubMed]
  • ZUCKER G, EISINGER RP, FLOCH MH, SINGER MM. Treatment of shock and prevention of ischemic necrosis with levarterenol-phentolamine mixtures. Circulation. 1960 Nov;22:935–937. [PubMed]
Articles from California Medicine are provided here courtesy of
BMJ Group

PubMed articles by these authors

Links